PMID- 29888048 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200930 IS - 2153-4063 (Print) IS - 2153-4063 (Electronic) VI - 2017 DP - 2018 TI - Characterizing drug-related adverse events by joint analysis of biomedical and genomic data: A case study of drug-induced pulmonary fibrosis. PG - 91-97 AB - Spontaneous reporting systems such as the FDA's adverse event reporting system (FAERS) present a great resource to mine for and analyze real-world medication usage. Our study is based on a central premise that FAERS captures unsuspected drug-related adverse events (AEs). Since drug-related AEs result for several reasons, no single approach will be able to predict the entire gamut of AEs. A fundamental premise of systems biology is that a full understanding of a biological process or phenotype (e.g., drug-related AE) requires that all the individual elements be studied in conjunction with one another. We therefore hypothesize that integrative analysis of FAERS-based drug-related AEs with the transcriptional signatures from disease models and drug treatments can lead to the generation of unbiased hypotheses for drug-induced AE-modulating mechanisms of action as well as drug combinations that may target those mechanisms. We test this hypothesis using drug-induced pulmonary fibrosis (DIPF) as a proof-of-concept study. FAU - Jiang, Alex AU - Jiang A AD - Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. AD - Comell University, Ithaca, New York, USA. FAU - Jegga, Anil G AU - Jegga AG AD - Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. AD - Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. AD - Department of Computer Science, University of Cincinnati College of Engineering, Cincinnati, Ohio, USA. LA - eng GR - R21 HL135368/HL/NHLBI NIH HHS/United States PT - Journal Article DEP - 20180518 PL - United States TA - AMIA Jt Summits Transl Sci Proc JT - AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science JID - 101539486 PMC - PMC5961825 EDAT- 2018/06/12 06:00 MHDA- 2018/06/12 06:01 PMCR- 2018/05/18 CRDT- 2018/06/12 06:00 PHST- 2018/06/12 06:00 [entrez] PHST- 2018/06/12 06:00 [pubmed] PHST- 2018/06/12 06:01 [medline] PHST- 2018/05/18 00:00 [pmc-release] AID - 2839468 [pii] PST - epublish SO - AMIA Jt Summits Transl Sci Proc. 2018 May 18;2017:91-97. eCollection 2018.